Temprinter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Temprinter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Temprinter Today - Breaking & Trending Today

AccuStem Sciences, Inc.: AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer

LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Exchange Commission , Trademark Office , Accustem Sciences Inc , Risk Factor In Accustem Sciences Inc , Stem Sciences , Kits Comprising Gene Signatures , Stratifying Breast Cancer Patients , Chief Executive Officer , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive ,

Tiziana Life Sciences Ltd.: StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort

NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.'s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY) (formerly AccuStem Sciences Ltd.), today announced ....

City Of , United Kingdom , Irina Koffler , Hana Malik , Milan University Medical School , Lifesci Advisors , Stem Cell Pathobiology Lab , Accustem Sciences Inc , Tiziana Life Sciences Ltd , Accustem Sciences Ltd , European Institute Of Oncology , Business Development , Life Sciences , Accustem Sciences , European Journal , European Institute , Royal Marsden Hospital , Breast Cancer , Salvatore Pece , Full Professor , Hormone Related Cancers , Investor Relations , Sci Advisors ,

Accustem Sciences, Inc: AccuStem's StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort

LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication ....

United States , City Of , United Kingdom , Milan University Medical School , Stem Cell Pathobiology Lab , Accustem Sciences Inc , European Institute Of Oncology , Stem Sciences , European Journal , European Institute , Royal Marsden Hospital , Breast Cancer , Salvatore Pece , Full Professor , Hormone Related Cancers , Accustem Sciences ,